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a sensitive cell-based assay for BoNT/A. Both the cell-based
assay and the endopeptidase assay yield results in a range
comparable to the MLD50.
http://dx.doi.org/10.1016/j.toxicon.2012.07.096
Enzymatic activity quantification of botulinum
neurotoxins A and B in serum by mass spectrometry
B.A. Parks a, J.D. Shearer b, J. Baudys a, S.R. Kalb a,
D.C. Sanford c, J.R. Barr a
aCenters for Disease Control and Prevention, Atlanta, GA, USA
bDynPort Vaccine Company LLC, Fredrick, MD, USA
cBattelle Biomedical Research Center, West Jefferson, OH, USA
E-mail address: iej7@cdc.gov (S.R. Kalb).
Purpose of study: A mass spectrometry (MS)-based
method for activity quantification of botulinum neuro-
toxin (BoNT) will be presented using 0.5 mL of serum.
Method validation will be discussed with applications
using challenged serum from a rhesus macaque time-
course study.
Methods used:MS analysis used a 4000 QTRAP running
in multiple-reaction-monitoring (MRM) mode. Separations
used an Acquity HPLC fitted with a BEH C18 column. BoNT
was extracted from all samples with antibody-coated
beads. The beads from these samples were then incubated
with a peptide substrate to produce cleavage products that
were monitored by MS.
Summary of results: Validation for this method
determined linear ranges as 0-90 and 0-32 mouse intra-
peritoneal lethal doses (MIPLD50) for BoNT serotypes A
and B respectively. Three bench quality control (QC)
samples were used for each calibration curve that bracket
the limit of quantitation (LOQ) and high end of each
calibration range. From this work the limit of detection
(LOD) was 0.18 MIPLD50, with a LOQ of 0.5 MIPLD50 for
each serotype. Blind QC samples were also analyzed that
demonstrated coefficient of variance values  20%. Using
BoNT challenged serum from a time-course study, our
MS-based method was compared to accepted technolo-
gies for BoNT analysis (i.e., the mouse bioassay). Using the
LOQ as a cutoff for the MS data, 66/116 samples were
found to be positive, compared to 22/116 for the mouse
bioassay.
Conclusions: From this work, it is now possible to
quantify BoNT activity with lower detection limits than
accepted techniques in the field with lower sample
requirements. In the future MS based activity quantifica-
tion could identify when antitoxins and other medical
countermeasures would be the most effective as one aspect
of the botulism pharmacokinetic profile.
The findings and conclusions in this report are those of
the authors and do not necessarily represent the official
position of the Centers for Disease Control and Prevention.
http://dx.doi.org/10.1016/j.toxicon.2012.07.097
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Purpose of study: Botulinum neurotoxin serotype
E (BoNT/E) outbreaks in the Great Lakes region cause large
annual avian mortality events with an estimated 17,000
bird deaths reported in 2007 alone. It is proposed that
environmental conditions following blooms of the native
algae Cladophora may promote growth of C. botulinum
within Great Lakes sediments and subsequent BoNT/E
production. BoNT/E may then be mobilized from the lake
bed through food chains consisting of exotic species. We set
out to develop a sensitive in vitro assay for diagnosis of
avian BoNT intoxication and analysis of drivers that
contribute to these outbreaks.
Methods used: The BoTestMatrix E BoNT/E detection
assay combines immuno-precipitation with high-affinity
endopeptidase activity detection by Förster Resonance
Energy Transfer to rapidly quantify BoNT/E activity in avian
blood and other samples with detection limits comparable
to the mouse bioassay.
Summary of results: Based upon the analysis of
archived blood samples (n¼87) collected from bird
carcasses during avian mortality investigations, BoTest
Matrix E detected picomolar quantities of BoNT/E following
a two–hour incubation and femtomolar quantities of BoNT/
E following extended incubation (24 hours), with 100%
diagnostic specificity and 91% diagnostic sensitivity.
Further, BoNT activity, as determined by the BoTest
Matrix E assay, correlated linearly with total BoNT/E
protein concentration contained within avian blood
samples, as measured by sandwich ELISA (slope ¼ 1.2). The
BoTest Matrix E assay also detected BoNT/E in spiked
mussels, fish and seaweed, suggesting its utility for analysis
of food web components.
Conclusions: Sensitive in vitro assays for the diagnosis
of botulinum intoxication in birds and for the identification
of BoNT/E in food web components will facilitate under-
standing of environmental toxin mobilization pathways
and will provide useful tools for the conservation of bird
species in the Great Lakes region.
http://dx.doi.org/10.1016/j.toxicon.2012.07.098
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